Investors and market participants can look forward to the unveiling of National Health Investors (NYSE: NHI) third quarter financial results on Tuesday 5th November 2024. This important update will be made available after market close.
the company is expected to report an estimated per share $0.73 profit for the quarter, as predicted by financial analysts on Wall Street. Furthermore, the company is anticipated to disclose a total revenue of $79.21 million during this period.
Wall street analysts expect the company to generate a total revenue of $323.36 million for the entire year. Additionally, these analysts also foresee the company achieving an estimated profit of $3.01 per share for the fiscal year.
During the equivalent quarter of the preceding year, the company's financial report highlighted a per-share income of $1.08. This significant amount was the outcome of the company's total revenue, which reached an impressive $80.11 million during that particular timeframe.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.18 | +11.3% | 84.97 M | +9.1% |
| Q1 2024 | $1.12 | +0.9% | 81.51 M | -1.1% |
| Q4 2023 | $1.09 | +28.2% | 79.47 M | +12.4% |
| Q3 2023 | $1.08 | +1.9% | 80.11 M | +5.0% |
| Q2 2023 | $1.06 | -15.9% | 77.88 M | +30.0% |
| *Growth on year-over-year basis | ||||
NHI has scheduled a conference call on 6th November 2024 at 11:00 AM eastern time to discuss the third quarter financial results and other related information.
The previous trading day saw National Health Investors (NHI) shares trading between $76.37 and $77.63, besides a volume of 262.20 thousand shares. The stock closed Friday's regular trading session at $76.45, marking 0.26 percent drop.
